前收市價 | 0.8700 |
開市 | 0.8200 |
買盤 | 0.7800 |
賣出價 | 0.8300 |
拍板 | 15.00 |
到期日 | 2024-10-18 |
今日波幅 | 0.7700 - 0.8600 |
合同範圍 | 無 |
成交量 | |
未平倉合約 | 6.58k |
In the most recent trading session, Walgreens Boots Alliance (WBA) closed at $17.53, indicating a +1.1% shift from the previous trading day.
Walgreens is ramping up its clinical trial offerings with Big Pharma players.
Walgreens Boots Alliance Inc. (NASDAQ:WBA) is facing tumultuous times as it grapples with a challenging turnaround, leading to a drastic decline in its stock value, marking its worst performance in over five years. The company’s shares plummeted by 18% in April, nearing a 26-year low, following a downward revision of its outlook. This revision was accompanied by concerns over decreased consumer spending and the revelation of a substantial unpaid tax liability amounting to $2.7 billion, adding to